Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsGeneral adult psychiatry — bipolar and related disorders

Psych · General adult psychiatry — bipolar and related disorders

Bipolar affective disorder

Also known as Bipolar disorder · Bipolar I · Bipolar II · Manic-depressive illness · Mania · Hypomania · Rapid cycling bipolar · Mixed features · Cyclothymia

Exam-exhaustive fellowship reference on bipolar affective disorder — DSM-5-TR and ICD-11 definitions; bipolar I/II and cyclothymia; mixed features and rapid cycling; organic and personality differentials; acute mania and bipolar depression algorithms with doses; lithium monitoring and anti-suicide evidence; BALANCE, STEP-BD, BOLDER/EMBOLDEN, lamotrigine maintenance; perinatal care; RANZCP/NICE/CANMAT/APA deltas. FRANZCP-primary, globally tagged.

high20 referencesUpdated 25 July 202615 min readVerification in progress

Your progress

Saved on this device.

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Mania or mixed features with active suicidal intent, psychosis, or catastrophic risk behaviour — same-day senior review and likely admission; do not leave on an empty safety plan
  • First mania after age 40, focal neurology, seizure, fever, or fluctuating attention — intensify organic work-up before locking a primary bipolar label
  • Antidepressant monotherapy in known or highly suspected bipolar I — high switch and destabilisation risk
  • Lithium toxicity: coarse tremor, ataxia, confusion, vomiting, dysarthria — stop lithium, check level urgently, hydrate, escalate
  • Valproate in people who can become pregnant without documented pregnancy-prevention counselling — major teratogen; hierarchy of avoidance
  • Postpartum first fortnight in bipolar illness — peak relapse window; protect sleep and re-establish prophylaxis early
On this page
Study tools

Your progress

Saved on this device.

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Mania or mixed features with active suicidal intent, psychosis, or catastrophic risk behaviour — same-day senior review and likely admission; do not leave on an empty safety plan
  • First mania after age 40, focal neurology, seizure, fever, or fluctuating attention — intensify organic work-up before locking a primary bipolar label
  • Antidepressant monotherapy in known or highly suspected bipolar I — high switch and destabilisation risk
  • Lithium toxicity: coarse tremor, ataxia, confusion, vomiting, dysarthria — stop lithium, check level urgently, hydrate, escalate
  • Valproate in people who can become pregnant without documented pregnancy-prevention counselling — major teratogen; hierarchy of avoidance
  • Postpartum first fortnight in bipolar illness — peak relapse window; protect sleep and re-establish prophylaxis early
One-line fellowship answer

Bipolar affective disorder is a recurrent polarity illness diagnosed by operational episode criteria (DSM-5-TR / ICD-11), managed by treating the current pole with polarity-safe agents, preventing relapse with lithium-first maintenance when appropriate, never using antidepressant monotherapy in bipolar I, and relentlessly managing suicide, sleep, substance use, and cardiometabolic risk.[13][14][3]

Meet the patient

A 27-year-old scaffolder is brought in by his brother. Five nights of two hours' sleep. A maxed-out credit card buying mining equipment for a cryptocurrency he is inventing. And a firm belief the health minister has personally summoned him to restructure the hospital. He is not sick, he tells you — he is finally well. In his chart, the registrar finds the sertraline his GP started last month "for depression".[20][14]

Every examiner's opener for this topic hides in that paragraph: what pole is he in, what do you stop, what do you start, and what do you watch for next?[14][2]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References20ShowHide
  1. [1]Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet, 2010.PMID 20092882
  2. [2]Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med, 2007.PMID 17392295
  3. [3]Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ, 2013.PMID 23814104
  4. [4]Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet, 2011.PMID 21851976
  5. [5]Miura T, Noma H, Furukawa TA, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis Lancet Psychiatry, 2014.PMID 26360999
  6. [6]Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am J Psychiatry, 2005.PMID 15994719
  7. [7]Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study) J Clin Psychopharmacol, 2006.PMID 17110817
  8. [8]Young AH, McElroy SL, Bauer M, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I) J Clin Psychiatry, 2010.PMID 20122369
  9. [9]Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Arch Gen Psychiatry, 2003.PMID 14609883
  10. [10]Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder J Clin Psychiatry, 2004.PMID 15096085
  11. [11]Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder J Clin Psychiatry, 2003.PMID 14628976
  12. [12]Loebel A, Cucchiaro J, Silva R, et al. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study Am J Psychiatry, 2014.PMID 24170180
  13. [13]Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder Bipolar Disord, 2018.PMID 29536616
  14. [14]Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Aust N Z J Psychiatry, 2021.PMID 33353391
  15. [15]Goodwin GM, Haddad PM, Ferrier IN, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology J Psychopharmacol, 2016.PMID 26979387
  16. [16]Patorno E, Huybrechts KF, Hernandez-Diaz S Lithium Use in Pregnancy and the Risk of Cardiac Malformations N Engl J Med, 2017.PMID 28854098
  17. [17]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
  18. [18]Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Arch Gen Psychiatry, 2011.PMID 21383262
  19. [19]Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group JAMA, 1994.PMID 8120960
  20. [20]Grande I, Berk M, Birmaher B, et al. Bipolar disorder Lancet, 2016.PMID 26388529
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute mania and hypomania managementGeneral adult psychiatry — bipolar and related disordersNextBipolar I disorderGeneral adult psychiatry — bipolar and related disorders